Drugs / Dendritic cells pulsed with tumor lysate
Dendritic cells pulsed with tumor lysate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03114631 | Jan 2017 → May 2019 | pancreatic neoplasm | The Republican Research and Practical Center for Epidemiology and Microbiology | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic cells pulsed with tumor lysate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03114631 ↗ |
| Modality | Cell therapy | “autologous dendritic cells, pulsed with tumor lysate” NCT03114631 ↗ |
| Route | Other | “injected subcutaneous (all patients) and intratumorally (when possible).” NCT03114631 ↗ |
| Route | Subcutaneous | “injected subcutaneous (all patients) and intratumorally (when possible).” NCT03114631 ↗ |